micro-community-banner
Profile Image
  • Add Media
  • Saved

1yr
Online Health Information Behaviour and Its Association With Statin Adherence in Patients With High Cardiovascular Risk: a Prospective Cohort Study

Online Health Information Behaviour and Its Association With Statin Adherence in Patients With High Cardiovascular Risk: a Prospective Cohort Study

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956144/

Statins are effective for preventing cardiovascular disease. However, many patients decide not to take statins because of negative influences, such as online misinformation. Online health information may affect decisions on...

Patients with high CV risk who actively searched for online health information had lower statin adherence, and this relationship was mediated by higher concerns about statins.

Profile Image
  • Saved

1yr
Improved Lipid-Lowering Treatment and Reduction in Cardiovascular Disease Burden in Homozygous Familial Hypercholesterolemia: the SAFEHEART Follow-Up Study

Improved Lipid-Lowering Treatment and Reduction in Cardiovascular Disease Burden in Homozygous Familial Hypercholesterolemia: the SAFEHEART Follow-Up Study

Source : https://pubmed.ncbi.nlm.nih.gov/38523000/

HoFH is a severe life threating disease with a high genetic and phenotypic variability. The improvement in lipid-lowering treatment and LDL-C levels have contributed to reduce ASCVD events.

Patients with ≥1 null variant are diagnosed younger, and show a more severe phenotype with higher LDL-C levels, more aortic valve disease, and earlier onset of ASCVD.

Profile Image
  • Saved

1yr
A Preview into the American College of Cardiology Scientific Session

The American College of Cardiology will host its annual meeting (ACC.24) in Atlanta from April 6 to 8, 2024. The theme of this year’s meeting is “Transforming Cardiovascular Care for All.” Click to access some of the highlights that caught our attention.

  • Saved

1yr
Patterns and Gaps in Guideline-Directed Statin Use for Atherosclerotic Cardiovascular Disease by Race and Ethnicity

Patterns and Gaps in Guideline-Directed Statin Use for Atherosclerotic Cardiovascular Disease by Race and Ethnicity

Source : https://pubmed.ncbi.nlm.nih.gov/38525197/

In patients with incident ASCVD, we describe suboptimal and heterogenous 1-year post-ASCVD guideline-directed statin use and 1-year post-ASCVD LDL-c control across disaggregated race and ethnicity groups. Findings may improve understanding...

Disaggregation of race/ethnicity groups uncovered suboptimal and heterogenous use of statins and achievement of LDL-C control after ASCVD events.

Profile Image
  • Saved

1yr
Lipoprotein(a) Is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease

Lipoprotein(a) Is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease

Source : https://pubmed.ncbi.nlm.nih.gov/38525410/

Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease

Lipoprotein(a) testing is essential for comprehensive CVD risk evaluation and is indicated in those with a personal or family history of premature CVD, if not all individuals.

Profile Image